Retraction notice to "Dapagliflozin attenuates diabetic cardiomyopathy via NRF2 protein upregulation-driven glutathione synthesis to inhibit myocardial ferroptosis" [Life Sciences 378 (2025) 123819] -
4 hours ago
- #Retraction
- #Diabetic Cardiomyopathy
- #Dapagliflozin
- Retraction notice for the article 'Dapagliflozin attenuates diabetic cardiomyopathy via NRF2 protein upregulation-driven glutathione synthesis to inhibit myocardial ferroptosis'.
- Originally published in Life Sciences, Volume 378, 2025, with DOI: 10.1016/j.lfs.2025.123819.
- Retracted in Life Sciences, 2026, with DOI: 10.1016/j.lfs.2026.124335.
- PMID for the original article: 40550388.
- PMID for the retraction notice: 41856849.